Related Experiment Videos
Experimental models of inflammatory bowel disease
Antoni Stadnicki1, Robert W Colman
1Department of Internal Medicine, Medical University of Silesia, Katowice, Poland. astadnic@wp.pl
Archivum Immunologiae Et Therapiae Experimentalis
|August 5, 2003
Summary
Experimental models advance the study of inflammatory bowel disease (IBD). Spontaneous colitis models in animals mimic human IBD, aiding in the development of new therapies.
Area of Science:
- Gastroenterology
- Immunology
- Pharmacology
Background:
- The causes and mechanisms of inflammatory bowel disease (IBD) are not fully understood.
- Experimental models of enterocolitis have improved understanding and research progress.
- IBD can be triggered by chemical, dietary, or microbial factors.
Purpose of the Study:
- To review the utility of various experimental models in studying IBD.
- To highlight models that mimic chronic, genetically controlled human IBD.
- To discuss how these models aid in evaluating anti-inflammatory drugs and therapies.
Main Methods:
- Utilizing spontaneous colitis models in non-human primates (cotton-top tamarin) and mice (C3H/HeJBir).
- Employing genetically susceptible rat strains (Lewis rats) for induced chronic enterocolitis.
- Developing transgenic and knockout rodent models targeting immunomodulatory molecules.
Main Results:
- Spontaneous models in monkeys and mice exhibit chronic inflammation, mirroring human IBD.
- Lewis rats develop chronic relapsing enterocolitis, unlike Buffalo or Fisher rats.
- Genetic models reveal inflammation linked to mutations in immunomodulatory molecules, suggesting IBD heterogeneity.
Conclusions:
- Experimental models are crucial for understanding IBD pathogenesis and evaluating treatments.
- Chronic, genetically controlled animal models offer better insights into human IBD.
- These models generate hypotheses, guide human studies, and suggest novel therapeutic strategies for IBD.